The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment
Clinical trial NCT03673215 · UNKNOWN
Trial details
- NCT number
- NCT03673215
- Sponsor
- Shenyang Sunshine Pharmaceutical Co., LTD.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-28
- Primary completion
- 2020-10-08
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.